Head-to-Head

Abbott Laboratories vs. Minerva Neurosciences, Inc

ABT

Abbott Laboratories

$103.00 -0.84%

VS NERV

Minerva Neurosciences, Inc

$2.03 -4.25%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTNERV
Market Cap $178.39 billion $105.65 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTNERV
Dividend Yield 2.45% —

ABT and NERV split the dividend factors evenly.

Risk & Sentiment

ABTNERV
Short Interest 0.57% 3.37%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, NERV overview, NERV financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.